At COHEAD Therapeutics, we are revolutionizing cancer treatment through our innovative CovAI platform. By combining cutting-edge AI-driven drug discovery with state-of-the-art computational chemistry, CovAI accelerates the development of high-impact cancer therapies. Our platform integrates machine learning, structural biology, and physics-based simulations to streamline the creation of novel therapeutics with precision and speed.
Led by a highly specialized team of scientists and backed by deep AI/ML expertise, COHEAD collaborates with leading academic institutions to push the boundaries of medicinal chemistry and computational biology. We are committed to targeting "undruggable" proteins and advancing precision oncology through groundbreaking science and technology.
COHEAD is at the forefront of transforming the future of cancer treatment.
Company Details
- Employees
- 1
- Founded
- -
- Address
- 11 Bates Rd, Lexington,massachusetts 02421,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://coheadtherapeutics.com/
- HQ
- Lexington, Massachusetts
Cohead Therapeutics Questions
Cohead Therapeutics's website is https://coheadtherapeutics.com/
Cohead Therapeutics's LinkedIn profile is https://www.linkedin.com/company/cohead-therapeutics
Cohead Therapeutics has
1 employees.
View email and phone details for 1
employees at Cohead Therapeutics.
Cohead Therapeutics's industry is
Biotechnology Research
Cohead Therapeutics's top competitors are
Gtn Tech,
Sampath Bank,
Veroxlabs,
99x,
Axiata Digital Labs,
Wso2,
Rootcode,
Forbes Technology Council,
Sampath It Solutions,
Arimac Digital.
Cohead Therapeutics's categories are Biotechnology Research
Cohead Therapeutics's founding year is 2024
